Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Argyropoulos

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
BMJ (Clinical Research Ed.)|September 11, 2001
Postpsychiatry. Might "properly funded psychiatry" be better description than psotpsychiatry?J K Melichar, S V Argyropoulos
Expert Opinion on Investigational Drugs|November 4, 2000
Substance P antagonists: novel agents in the treatment of depressionS V Argyropoulos, D J Nutt
Psychopharmacology|February 6, 1998
Anhedonia and chronic mild stress model in depressionS V Argyropoulos, D J Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
The use of benzodiazepines in anxiety and other disordersS V Argyropoulos, D J Nutt
The Psychiatric Clinics of North America|November 29, 2001
Brain function in social anxiety disorderS V Argyropoulos, C J Bell, D J Nutt
Journal of Clinical Psychopharmacology|July 31, 2001
Arthritis and serotonergic antidepressantsS D Hood, S V Argyropoulos, D J Nutt
Acta Neuropsychiatrica|March 18, 2016
The role of serotonin in panic: evidence from tryptophan depletion studiesA C Pyle, S V Argyropoulos, D J Nutt
Acta Psychiatrica Scandinavica|May 1, 2001
Social phobia: illness or illusion?S V Argyropoulos, S D Hood, D J Nutt
Pharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drugs. Part 1: Basic neurobiologyJ J Sandford, S V Argyropoulos, D J Nutt
Pharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxietyS V Argyropoulos, J J Sandford, D J Nutt
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
BMJ (Clinical Research Ed.)|September 11, 2001
Postpsychiatry. Might "properly funded psychiatry" be better description than psotpsychiatry?J K Melichar, S V Argyropoulos
Expert Opinion on Investigational Drugs|November 4, 2000
Substance P antagonists: novel agents in the treatment of depressionS V Argyropoulos, D J Nutt
Psychopharmacology|February 6, 1998
Anhedonia and chronic mild stress model in depressionS V Argyropoulos, D J Nutt
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000
The use of benzodiazepines in anxiety and other disordersS V Argyropoulos, D J Nutt
The Psychiatric Clinics of North America|November 29, 2001
Brain function in social anxiety disorderS V Argyropoulos, C J Bell, D J Nutt
Journal of Clinical Psychopharmacology|July 31, 2001
Arthritis and serotonergic antidepressantsS D Hood, S V Argyropoulos, D J Nutt
Acta Neuropsychiatrica|March 18, 2016
The role of serotonin in panic: evidence from tryptophan depletion studiesA C Pyle, S V Argyropoulos, D J Nutt
Acta Psychiatrica Scandinavica|May 1, 2001
Social phobia: illness or illusion?S V Argyropoulos, S D Hood, D J Nutt
Pharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drugs. Part 1: Basic neurobiologyJ J Sandford, S V Argyropoulos, D J Nutt
Pharmacology & Therapeutics|May 5, 2001
The psychobiology of anxiolytic drug. Part 2: Pharmacological treatments of anxietyS V Argyropoulos, J J Sandford, D J Nutt
Pageof 2